TrophiCell NEWS

#1 New University spin-out developing novel adult stem cell-based Therapies

February 14, 2024

The University of Liverpool has launched a new spin-out company, TrophiCell, that has developed a revolutionary approach to harness the therapeutic potential of adult Mesenchymal Stem Cells (MSCs).



TrophiCell optimises ‘trophic repair’ – the process by which MSCs secrete factors that promote repair and reduce inflammation in chronic conditions such as osteoarthritis and liver disease. TrophiCell has patented a new approach to cell therapy production that can reliably treat a range of diseases at a scale never previously possible with MSCs....Read More